Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Padovan

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Neuroscience|March 24, 2009
Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's diseaseF E Padovan-Neto, M B Echeverry, V Tumas, et al.
The Journal of Biological Chemistry|October 24, 2001
B-lymphocytes from malignant hyperthermia-susceptible patients have an increased sensitivity to skeletal muscle ryanodine receptor activatorsT Girard, D Cavagna, E Padovan, et al.
Human Immunology|February 13, 2001
Modulation of dendritic cell phenotype and mobility by tumor cells in vitroE Remmel, L Terracciano, C Noppen, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|November 20, 2010
Lack of tolerance for the anti-dyskinetic effects of 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, in ratsN Novaretti, F E Padovan-Neto, V Tumas, et al.
The European Journal of Neuroscience|February 15, 2024
Sodium nitroprusside enhances stepping test performance and increases medium spiny neurons responsiveness to cortical inputs in a rat model of Levodopa-induced dyskinesiasDanilo Leandro Ribeiro, Rayanne Poletti Guimarães, Keila Bariotto-Dos-Santos, et al.
Cancer Gene Therapy|October 11, 2001
Immunogenicity of nonreplicating recombinant vaccinia expressing HLA-A201 targeted or complete MART-1/Melan-A antigenA Schütz, D Oertli, W R Marti, et al.
Frontiers in Physiology|October 12, 2012
Investigations into Potential Extrasynaptic Communication between the Dopaminergic and Nitrergic SystemsM Mitkovski, F E Padovan-Neto, R Raisman-Vozari, et al.
Frontiers in Bioscience (Elite Edition)|January 2, 2015
Nitric oxide, a new player in L-DOPA-induced dyskinesia?Elaine Del-Bel, Fernando E Padovan-Neto, Mariza Bortolanza, et al.
Molecular Neurobiology|August 31, 2019
Selective Regulation of 5-HT1B Serotonin Receptor Expression in the Striatum by Dopamine Depletion and Repeated L-DOPA Treatment: Relationship to L-DOPA-Induced DyskinesiasFernando E Padovan-Neto, Santanna Patterson, Nivea M F Voelkner, et al.
Neurobiology of Disease|December 3, 2014
Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's diseaseMariza Bortolanza, Roberta Cavalcanti-Kiwiatkoski, Fernando E Padovan-Neto, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Neuroscience|March 24, 2009
Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's diseaseF E Padovan-Neto, M B Echeverry, V Tumas, et al.
The Journal of Biological Chemistry|October 24, 2001
B-lymphocytes from malignant hyperthermia-susceptible patients have an increased sensitivity to skeletal muscle ryanodine receptor activatorsT Girard, D Cavagna, E Padovan, et al.
Human Immunology|February 13, 2001
Modulation of dendritic cell phenotype and mobility by tumor cells in vitroE Remmel, L Terracciano, C Noppen, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|November 20, 2010
Lack of tolerance for the anti-dyskinetic effects of 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, in ratsN Novaretti, F E Padovan-Neto, V Tumas, et al.
The European Journal of Neuroscience|February 15, 2024
Sodium nitroprusside enhances stepping test performance and increases medium spiny neurons responsiveness to cortical inputs in a rat model of Levodopa-induced dyskinesiasDanilo Leandro Ribeiro, Rayanne Poletti Guimarães, Keila Bariotto-Dos-Santos, et al.
Cancer Gene Therapy|October 11, 2001
Immunogenicity of nonreplicating recombinant vaccinia expressing HLA-A201 targeted or complete MART-1/Melan-A antigenA Schütz, D Oertli, W R Marti, et al.
Frontiers in Physiology|October 12, 2012
Investigations into Potential Extrasynaptic Communication between the Dopaminergic and Nitrergic SystemsM Mitkovski, F E Padovan-Neto, R Raisman-Vozari, et al.
Frontiers in Bioscience (Elite Edition)|January 2, 2015
Nitric oxide, a new player in L-DOPA-induced dyskinesia?Elaine Del-Bel, Fernando E Padovan-Neto, Mariza Bortolanza, et al.
Molecular Neurobiology|August 31, 2019
Selective Regulation of 5-HT1B Serotonin Receptor Expression in the Striatum by Dopamine Depletion and Repeated L-DOPA Treatment: Relationship to L-DOPA-Induced DyskinesiasFernando E Padovan-Neto, Santanna Patterson, Nivea M F Voelkner, et al.
Neurobiology of Disease|December 3, 2014
Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's diseaseMariza Bortolanza, Roberta Cavalcanti-Kiwiatkoski, Fernando E Padovan-Neto, et al.
Pageof 5